Publication

A Sialylated Glycan Microarray Reveals Novel Interactions of Modified Sialic Acids with Proteins and Viruses*

Downloadable Content

Persistent URL
Last modified
  • 02/20/2025
Type of Material
Authors
    Xuezheng Song, Emory UniversityHai Yu, University of California DavisXi Chen, Emory UniversityYi Lasanajak, Emory UniversityMary M. Tappert, University of OklahomaGillian M. Air, University of OklahomaVinod K. Tiwari, University of California DavisHongzhi Cao, University of California DavisHarshal A. Chokhawala, University of California DavisHaojie Zheng, University of California DavisRichard D. Cummings, Emory UniversityDavid Smith, Emory University
Language
  • English
Date
  • 2011-09-09
Publisher
  • American Society for Biochemistry and Molecular Biology
Publication Version
Copyright Statement
  • © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 0021-9258
Volume
  • 286
Issue
  • 36
Start Page
  • 31610
End Page
  • 31622
Grant/Funding Information
  • This work was also supported by Defense Advanced Research Projects Agency Grant HR0011-10-00 (to R. D. C.) and Oklahoma Center for the Advancement of Science and Technology Grant HR09-001 (to G. M. A.).
  • This work was supported, in whole or in part, by National Institutes of Health (NIH) Grant RO1GM085448 (to D. F. S.), a bridging grant from the Consortium for Functional Glycomics under NIGMS, NIH Grant GM62116 (to R. D. C.), and NIH Grant GM076360 (to X. C.).
Abstract
  • Many glycan-binding proteins in animals and pathogens recognize sialic acid or its modified forms, but their molecular recognition is poorly understood. Here we describe studies on sialic acid recognition using a novel sialylated glycan microarray containing modified sialic acids presented on different glycan backbones. Glycans terminating in β-linked galactose at the non-reducing end and with an alkylamine-containing fluorophore at the reducing end were sialylated by a one-pot three-enzyme system to generate α2–3- and α2–6-linked sialyl glycans with 16 modified sialic acids. The resulting 77 sialyl glycans were purified and quantified, characterized by mass spectrometry, covalently printed on activated slides, and interrogated with a number of key sialic acid-binding proteins and viruses. Sialic acid recognition by the sialic acid-binding lectins Sambucus nigra agglutinin and Maackia amurensis lectin-I, which are routinely used for detecting α2–6- and α2–3-linked sialic acids, are affected by sialic acid modifications, and both lectins bind glycans terminating with 2-keto-3-deoxy-d-glycero-d-galactonononic acid (Kdn) and Kdn derivatives stronger than the derivatives of more common N-acetylneuraminic acid (Neu5Ac) and N-glycolylneuraminic acid (Neu5Gc). Three human parainfluenza viruses bind to glycans terminating with Neu5Ac or Neu5Gc and some of their derivatives but not to Kdn and its derivatives. Influenza A virus also does not bind glycans terminating in Kdn or Kdn derivatives. An especially novel aspect of human influenza A virus binding is its ability to equivalently recognize glycans terminated with either α2–6-linked Neu5Ac9Lt or α2–6-linked Neu5Ac. Our results demonstrate the utility of this sialylated glycan microarray to investigate the biological importance of modified sialic acids in protein-glycan interactions.
Author Notes
  • To whom correspondence may be addressed: Dept. of Biochemistry, Emory University School of Medicine, O. Wayne Rollins Research Center, 1510 Clifton Rd., Suite 4001, Atlanta, GA 30322. Tel.: 404-727-5962; Fax: 404-727-2738; E-mail: rdcummi@emory.edu.
Keywords
Research Categories
  • Chemistry, Biochemistry

Tools

Relations

In Collection:

Items